192 related articles for article (PubMed ID: 36648496)
1. Recent progress in nanomedicines for imaging and therapy of brain tumors.
Hasan I; Roy S; Guo B; Du S; Tao W; Chang C
Biomater Sci; 2023 Feb; 11(4):1270-1310. PubMed ID: 36648496
[TBL] [Abstract][Full Text] [Related]
2. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-assisted brain delivery of nanomedicines for brain tumor therapy: advance and prospect.
Zhang S; Zhang S; Luo S; Tang P; Wan M; Wu D; Gao W
J Nanobiotechnology; 2022 Jun; 20(1):287. PubMed ID: 35710426
[TBL] [Abstract][Full Text] [Related]
4. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
[TBL] [Abstract][Full Text] [Related]
5. Covalent nano delivery systems for selective imaging and treatment of brain tumors.
Ljubimova JY; Sun T; Mashouf L; Ljubimov AV; Israel LL; Ljubimov VA; Falahatian V; Holler E
Adv Drug Deliv Rev; 2017 Apr; 113():177-200. PubMed ID: 28606739
[TBL] [Abstract][Full Text] [Related]
6. Silica nanoparticles for brain cancer.
Feng Y; Cao Y; Singh R; Janjua TI; Popat A
Expert Opin Drug Deliv; 2023; 20(12):1749-1767. PubMed ID: 37905998
[TBL] [Abstract][Full Text] [Related]
7. A state-of-the-art liposome technology for glioblastoma treatment.
Hasan I; Roy S; Ehexige E; Wu R; Chen Y; Gao Z; Guo B; Chang C
Nanoscale; 2023 Nov; 15(45):18108-18138. PubMed ID: 37937394
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of preclinical mouse models of high-grade glioma for nanomedicine research: the importance of reproducing blood-brain barrier heterogeneity.
Brighi C; Reid L; Genovesi LA; Kojic M; Millar A; Bruce Z; White AL; Day BW; Rose S; Whittaker AK; Puttick S
Theranostics; 2020; 10(14):6361-6371. PubMed ID: 32483457
[TBL] [Abstract][Full Text] [Related]
9. A Comprehensive Review on Nanomedicine: Promising Approach for Treatment of Brain Tumor through Intranasal Administration.
Bahadur S; Prakash A
Curr Drug Targets; 2023; 24(1):71-88. PubMed ID: 36278468
[TBL] [Abstract][Full Text] [Related]
10. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
11. Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruption.
Janowicz PW; Houston ZH; Bunt J; Fletcher NL; Bell CA; Cowin G; Howard CB; Taslima D; Westra van Holthe N; Prior A; Soh V; Ghosh S; Humphries J; Huda P; Mahler SM; Richards LJ; Thurecht KJ
Biomaterials; 2022 Apr; 283():121416. PubMed ID: 35217483
[TBL] [Abstract][Full Text] [Related]
12. Membrane-encapsulated camouflaged nanomedicines in drug delivery.
Ghosh S; Girigoswami K; Girigoswami A
Nanomedicine (Lond); 2019 Aug; 14(15):2067-2082. PubMed ID: 31355709
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of nanomedicines for prostate cancer: An update.
Lakshmanan VK
Investig Clin Urol; 2016 Jan; 57(1):21-9. PubMed ID: 26966723
[TBL] [Abstract][Full Text] [Related]
14. Patented nanomedicines for the treatment of brain tumors.
Caruso G; Raudino G; Caffo M
Pharm Pat Anal; 2013 Nov; 2(6):745-54. PubMed ID: 24237240
[TBL] [Abstract][Full Text] [Related]
15. Drug delivery and targeting to brain tumors: considerations for crossing the blood-brain barrier.
Omidi Y; Kianinejad N; Kwon Y; Omidian H
Expert Rev Clin Pharmacol; 2021 Mar; 14(3):357-381. PubMed ID: 33554678
[No Abstract] [Full Text] [Related]
16. Evaluating Nanomedicines: Obstacles and Advancements.
Swierczewska M; Crist RM; McNeil SE
Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
[TBL] [Abstract][Full Text] [Related]
17. Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers.
Mulvihill JJ; Cunnane EM; Ross AM; Duskey JT; Tosi G; Grabrucker AM
Nanomedicine (Lond); 2020 Jan; 15(2):205-214. PubMed ID: 31916480
[TBL] [Abstract][Full Text] [Related]
18. Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
Harilal S; Jose J; Parambi DGT; Kumar R; Mathew GE; Uddin MS; Kim H; Mathew B
J Pharm Pharmacol; 2019 Sep; 71(9):1370-1383. PubMed ID: 31304982
[TBL] [Abstract][Full Text] [Related]
19. Targeting central nervous system pathologies with nanomedicines.
Mizrahy S; Gutkin A; Decuzzi P; Peer D
J Drug Target; 2019; 27(5-6):542-554. PubMed ID: 30296187
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.
Tam VH; Sosa C; Liu R; Yao N; Priestley RD
Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]